These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
59 related articles for article (PubMed ID: 3073570)
21. Immunoblot test with recombinant HIV antigens. Motz M; Soutschek-Bauer E; Frösner GG; Gürtler L; Schall M; Wolf H Lancet; 1987 Nov; 2(8567):1093. PubMed ID: 2890006 [No Abstract] [Full Text] [Related]
22. [The immunoenzyme detection of the HIV-1 antigen by using monoclonal antibodies to protein p24]. Shumaĭ EP; Vorob'ev SM; Makarova NE; Tugizov ShM; Zverev VV; Kushch AA Vopr Virusol; 1992; 37(5-6):229-32. PubMed ID: 1290220 [TBL] [Abstract][Full Text] [Related]
23. [Expression and characterization of HIV-1 Gag p17-p24 protein]. Li TY; Jin NY; Wang HW; Guo ZR; Fang HH; An RG; Yin Z Sheng Wu Gong Cheng Xue Bao; 2000 Jan; 16(1):65-8. PubMed ID: 10883279 [TBL] [Abstract][Full Text] [Related]
24. SIV, STLV-I and type D retrovirus antibodies in captive rhesus macaques and immunoblot reactivity to SIV p27 in human and rhesus monkey sera. Lairmore MD; Lerche NW; Schultz KT; Stone CM; Brown BG; Hermann LM; Yee JA; Jennings M AIDS Res Hum Retroviruses; 1990 Nov; 6(11):1233-8. PubMed ID: 1706606 [TBL] [Abstract][Full Text] [Related]
25. Highly immunogenic human immunodeficiency viruslike particles are produced by recombinant vaccinia virus-infected cells. Vzorov AN; Bukrinsky MI; Grigoriev VB; Tentsov YYu ; Bukrinskaya AG AIDS Res Hum Retroviruses; 1991 Jan; 7(1):29-36. PubMed ID: 1901721 [TBL] [Abstract][Full Text] [Related]
26. HIV-1 core proteins expressed from recombinant vaccinia viruses. Rautmann G; Kieny MP; Brandely R; Dott K; Girard M; Montagnier L; Lecocq JP AIDS Res Hum Retroviruses; 1989 Apr; 5(2):147-57. PubMed ID: 2713165 [TBL] [Abstract][Full Text] [Related]
27. [The immunoenzyme test system for detection of HIV-1 antigens based on using immune polyclonal anti-HIV serum and monoclonal antibodies against gene GAG HIV-1 proteins]. Trushinskaia GN; Simonov VI; Makarova NE; Nosik DN; Kushch AA; Gibadulin RA Vestn Ross Akad Med Nauk; 1992; (9-10):43-7. PubMed ID: 1283720 [TBL] [Abstract][Full Text] [Related]
28. Decline in CTL and antibody responses to HIV-1 p17 and p24 antigens in HIV-1-infected hemophiliacs irrespective of disease progression. A 5-year follow-up study. O'Toole CM; Lowdell MW; Chargelegue D; Colvin BT AIDS Res Hum Retroviruses; 1992 Aug; 8(8):1361-8. PubMed ID: 1281655 [TBL] [Abstract][Full Text] [Related]
29. Immunization of human HIV-seronegative volunteers with recombinant p17/p24:Ty virus-like particles elicits HIV-1 p24-specific cellular and humoral immune responses. Martin SJ; Vyakarnam A; Cheingsong-Popov R; Callow D; Jones KL; Senior JM; Adams SE; Kingsman AJ; Matear P; Gotch FM AIDS; 1993 Oct; 7(10):1315-23. PubMed ID: 8267904 [TBL] [Abstract][Full Text] [Related]
30. Evaluation of a human immunodeficiency virus test algorithm utilizing a recombinant protein enzyme immunoassay. Lepine DG; Neumann PW; Frenette SL; O'Shaughnessy MV J Clin Microbiol; 1990 Jun; 28(6):1169-71. PubMed ID: 2199490 [TBL] [Abstract][Full Text] [Related]
31. [Persistent viruses in serological diagnosis of HIV infection]. Khaitov RM; Glushchenko MV; Trubcheninova LP; Prokopenko VD Vestn Ross Akad Med Nauk; 1992; (9-10):59-62. PubMed ID: 1283724 [TBL] [Abstract][Full Text] [Related]
32. HIV-1 gag proteins in virions and in infected cell fractions. Sharova NK; Grigor'ev VB; Bukrinskaya AG Biomed Sci; 1991; 2(3):279-84. PubMed ID: 1751761 [TBL] [Abstract][Full Text] [Related]
33. Conserved immunogenic region of a major core protein (p24) of human and simian immunodeficiency viruses. Koito A; Hattori T; Matsushita S; Maeda Y; Nozaki C; Sagawa K; Takatsuki K AIDS Res Hum Retroviruses; 1988 Dec; 4(6):409-17. PubMed ID: 2464360 [TBL] [Abstract][Full Text] [Related]
34. Validation of a new immunoblot assay (LiaTek HIV III) for confirmation of human immunodeficiency virus infection. Zaaijer HL; van Rixel GA; Kromosoeto JN; Balgobind-Ramdas DR; Cuypers HT; Lelie PN Transfusion; 1998 Aug; 38(8):776-81. PubMed ID: 9709787 [TBL] [Abstract][Full Text] [Related]
35. [Formation of virus-like particles by HIV-1 Gag proteins, expressed by a recombinant vaccinia virus]. Vzorov AN; Tentsov IuIu; Grigor'ev VB; Shulenin SA; Garaev MM; Bogdan OP; Bukrinskaia AG Mol Biol (Mosk); 1990; 24(6):1666-74. PubMed ID: 2094814 [TBL] [Abstract][Full Text] [Related]
36. Variable and conserved neutralization antigens of human immunodeficiency virus. Weiss RA; Clapham PR; Weber JN; Dalgleish AG; Lasky LA; Berman PW Nature; 1986 Dec 11-17; 324(6097):572-5. PubMed ID: 2431324 [TBL] [Abstract][Full Text] [Related]
37. [The reasons for false positive results with recombinant preparations in HIV infection]. Karal'nik BV; Riazanova GL; Shuratov IKh Zh Mikrobiol Epidemiol Immunobiol; 1991 Sep; (9):32-5. PubMed ID: 1836923 [TBL] [Abstract][Full Text] [Related]
38. Comparison of false-positive reactions in direct-binding anti-HIV ELISA using cell lysate or recombinant antigens. Craske J; Turner A; Abbott R; Collier M; Gunson HH; Lee D; Martlew V; Howell P; Love E Vox Sang; 1990; 59(3):160-6. PubMed ID: 2264319 [TBL] [Abstract][Full Text] [Related]
39. Science and technology in mitigating AIDS. Overby LR; Allain JP Transfus Med Rev; 1988 Dec; 2(4):296-8. PubMed ID: 2980095 [TBL] [Abstract][Full Text] [Related]
40. [Causes of false-positive results in serological studies of HIV infection]. Orlova VM; Siziakina LP; Dosiagaeva LI Klin Lab Diagn; 1993; (3):44-7. PubMed ID: 8963538 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]